Section Arrow
PRFX.NASDAQ
- PainReform Ltd
Quotes are at least 15-min delayed:2024/05/20 22:50 EDT
Last
 0.7705
-0.075 (-8.87%)
Day High 
0.8561 
Prev. Close
0.8455 
1-M High
0.9696 
Volume 
110.84K 
Bid
0.779
Ask
0.81
Day Low
0.75 
Open
0.85 
1-M Low
0.75 
Market Cap 
2.09M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.82 
20-SMA 0.85 
50-SMA 1.31 
52-W High 26.41 
52-W Low 0.69 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.74/-2.02
Enterprise Value
2.12M
Balance Sheet
Book Value Per Share
0.75
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp0.1337-0.0389-22.54%-- 
TLRYTilray Brands1.94-0.04-2.02%-- 
VTRSViatris11.07+0.09+0.82%227.2PE
HLNHaleon plc8.51--0.000%28.63PE
CGCCanopy Growth Corp10.13-0.72-6.64%-- 
Quotes are at least 15-min delayed:2024/05/20 22:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.